Skip to main content

Table 1 Schedule of enrolment, interventions, and assessments

From: Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial

Schedule of activities

 

Enrolment

Allocation

Post-allocation

Close-out

Time Point

Week 1

Week 2

Week 3–5

Week 6

Week 7–10

Week 11

Week 12–15

Week 16

Week 17

Enrolment

 Screening

        

 Eligibility screen

        

 Informed consent

        

 Computed tomography (CT) and collection of laboratory tests

        

 Baseline consultation (allocation)

 

       

Interventions

 Intervention start

 

       

 Telephone follow-up

  

 

 

  

 Return consultation 1

   

     

 Return consultation 2

     

   

 Return consultation 3

       

 

Assessments

 Computed tomography (CT) and laboratory tests

       

 

 Final consultation